BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3490381)

  • 1. Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy.
    Sochor H; Schelbert HR; Schwaiger M; Henze E; Phelps ME
    Eur J Nucl Med; 1986; 12 Suppl():S66-9. PubMed ID: 3490381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism.
    Schelbert HR; Henze E; Schon HR; Keen R; Hansen H; Selin C; Huang SC; Barrio JR; Phelps ME
    Am Heart J; 1983 Mar; 105(3):492-504. PubMed ID: 6600872
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic imaging of patients with cardiomyopathy.
    Geltman EM
    Circulation; 1991 Sep; 84(3 Suppl):I265-72. PubMed ID: 1884495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of regional myocardial ischemia by positron-emission computed tomography.
    Schelbert HR; Henze E; Phelps ME; Kuhl DE
    Am Heart J; 1982 Apr; 103(4 Pt 2):588-97. PubMed ID: 6978056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction.
    Schelbert HR; Henze E; Sochor H; Grossman RG; Huang SC; Barrio JR; Schwaiger M; Phelps ME
    Am Heart J; 1986 Jun; 111(6):1055-64. PubMed ID: 3487240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Planar scintigraphy versus PET in measuring fatty acid metabolism of the heart].
    Kaiser KP; Feinendegen LE
    Herz; 1987 Feb; 12(1):41-50. PubMed ID: 3493962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium.
    Schön HR; Schelbert HR; Robinson G; Najafi A; Huang SC; Hansen H; Barrio J; Kuhl DE; Phelps ME
    Am Heart J; 1982 Apr; 103(4 Pt 1):532-47. PubMed ID: 6801944
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of myocardial fatty acid metabolism with 1-11C-palmitate.
    Geltman EM
    J Nucl Cardiol; 1994; 1(2 Pt 2):S15-22. PubMed ID: 9420693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs.
    Schelbert HR; Henze E; Keen R; Schon HR; Hansen H; Selin C; Huang SC; Barrio JR; Phelps ME
    Am Heart J; 1983 Oct; 106(4 Pt 1):736-50. PubMed ID: 6604447
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of myocardial metabolism with 11C-palmitate. Comparison with 123I-heptadecanoic acid.
    Lerch RA; Bergmann SR
    Eur Heart J; 1985 Aug; 6 Suppl B():21-7. PubMed ID: 3878785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fatty acid metabolism using C-11 palmitate: (1). Resting study].
    Tamaki N; Yonekura Y; Magata Y; Saji H; Fujibayashi Y; Sasayama S; Yamashita K; Ohtani H; Fujita T; Yamada T
    Kaku Igaku; 1990 Apr; 27(4):313-21. PubMed ID: 2376917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron tomography and myocardial metabolism: an overview.
    Sobel BE
    Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
    Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
    J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I-123 heptadecanoic acid--value and limitations in comparison with C-11 palmitate.
    Schön HR
    Eur J Nucl Med; 1986; 12 Suppl():S16-9. PubMed ID: 3490371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-phenylpentadecanoic acid as a tracer of cardiac free fatty acid metabolism. Experimental and clinical results.
    Reske SN
    Eur Heart J; 1985 Aug; 6 Suppl B():39-47. PubMed ID: 3936714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C- 11 palmitic acid in acutely ischemic myocardium.
    Schön HR; Schelbert HR; Najafi A; Hansen H; Huang H; Barrio J; Phelps ME
    Am Heart J; 1982 Apr; 103(4 Pt 1):548-61. PubMed ID: 6801945
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial imaging with radiolabelled free fatty acids: a critical review.
    van der Wall EE
    Eur Heart J; 1985 Aug; 6 Suppl B():29-38. PubMed ID: 3910439
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study.
    Uehara T; Ishida Y; Hayashida K; Shimonagata T; Miyake Y; Sago M; Oka H; Nagata S; Miyatake K; Nishimura T
    Ann Nucl Med; 1998 Apr; 12(2):95-103. PubMed ID: 9637280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.